Mitochondrial Function & Ageing Research

Summary

Mitochondria generate most cellular ATP and act as signalling hubs for stress and cell death. Mitochondrial capacity declines measurably with age in most tissues. Whether that decline causes ageing or reflects it remains contested, and the free-radical theory that once dominated the field has been substantially revised.

Last reviewed 2026-09-01

What it is

Mitochondria are double-membraned organelles carrying their own circular DNA, responsible for oxidative phosphorylation, calcium buffering, apoptosis regulation and a range of signalling functions.

Harman's free radical theory of ageing (1956) and its mitochondrial extension (1972) framed the field for decades. Failures of antioxidant supplementation trials and mice with elevated mitochondrial ROS that did not age faster forced a substantial revision.

Endosymbiotic bacterial ancestry, which is why they retain their own genome and divide independently of the cell.

Mitochondrial function is measurable in humans non-invasively via phosphorus MRS and by biopsy respirometry, making it one of the more tractable ageing processes to study.

How it works

In plain terms

Mitochondria burn fuel to make energy. With age they become less efficient, damaged ones are cleared less effectively, and fewer new ones are made. The result is less energy capacity and more stress signalling.

Technical detail

Age-related changes include reduced electron transport chain complex activity (notably complexes I and IV), accumulation of mitochondrial DNA point mutations and deletions, altered cristae morphology with cardiolipin remodelling, impaired mitophagy through PINK1/Parkin signalling, and reduced biogenesis via the PGC-1α axis. Fusion and fission dynamics shift toward fragmentation. Rather than ROS being purely damaging, moderate ROS signalling (mitohormesis) appears necessary for adaptive responses, which is why blanket antioxidant supplementation has generally failed.

Pathways involved

Electron transport chain complex activity and supercomplex assembly
mtDNA mutation and heteroplasmy accumulation
PINK1/Parkin mitophagy
PGC-1α-driven mitochondrial biogenesis
Fusion/fission dynamics (MFN1/2, OPA1, DRP1)
Cardiolipin composition and cristae structure

Current research

Laboratory research

Respirometry in isolated mitochondria and permeabilised fibres is the standard functional readout; cardiolipin and supercomplex analyses underpin structural work.

Animal research

The mtDNA mutator mouse ages prematurely, supporting a causal role for mitochondrial genome damage. Exercise and caloric restriction increase biogenesis markers across species. Mitochondrially targeted compounds improve function in disease models more reliably than in healthy ones.

Human research

Skeletal muscle mitochondrial capacity declines roughly 8% per decade in cross-sectional studies, though a large share of that is attributable to reduced physical activity rather than age alone. Exercise training reverses much of the deficit even in older adults. Mitochondrially targeted agents such as elamipretide have produced mixed clinical trial results.

Ongoing research

NAD+ precursor trials, mitophagy inducers such as urolithin A, and elamipretide programmes are the main clinical threads.

What is being investigated

Exercise as the most reliable intervention for mitochondrial capacity
NAD+ precursor supplementation (nicotinamide riboside, NMN)
Mitophagy induction with urolithin A
Cardiolipin-targeted peptides in mitochondrial disease
Mitochondrial biomarkers as measures of biological age

These are research directions reported in the literature, not established effects or recommendations.

Risks, limitations and unknowns

Read this section before the rest

Antioxidant supplementation trials have repeatedly failed and in some cases showed harm, because ROS signalling is functionally necessary
Cross-sectional mitochondrial decline is heavily confounded by physical inactivity
Biomarker improvement in NAD+ trials has rarely translated into functional endpoints
Mitochondrially targeted drugs have shown benefit mainly in disease populations, not healthy ageing
Measurement methods differ substantially between studies, limiting comparability

Evidence ratings

Laboratory studies

Strong

Mechanisms of mitochondrial decline well characterised.

Animal studies

Strong

Mutator mouse and exercise data are robust.

Human studies

Moderate

Decline well documented; interventions beyond exercise less convincing.

Exercise as intervention

Strong

Reproducibly improves capacity at all ages studied.

References

[1]Mitochondrial dysfunction and ageing reviews — PubMed, 2010–present
[2]mtDNA mutator mouse studies — PubMed, 2004–present
[3]Exercise and mitochondrial biogenesis in older adults — PubMed, 2010–present
[4]NAD+ precursor clinical trials — PubMed, 2016–present
Reference links open searches and records on PubMed and ClinicalTrials.gov so that every statement above can be traced to primary literature.

Frequently asked questions

Do mitochondria decline with age?+

Measured capacity declines with age in most tissues, though a substantial part of that in humans reflects reduced physical activity rather than age itself.

Is the free radical theory of ageing correct?+

It has been substantially revised. Moderate ROS act as necessary signals, and mice with elevated mitochondrial ROS do not consistently age faster.

What is mitophagy?+

The selective recycling of damaged mitochondria, largely regulated by PINK1 and Parkin. It becomes less efficient with age.

Do NAD+ boosters work?+

Nicotinamide riboside and NMN reliably raise blood NAD+ metabolites in trials. Functional benefit in healthy adults has not been consistently demonstrated.

What is the best evidenced way to improve mitochondrial function?+

Exercise training, particularly combined endurance and resistance work, has the strongest and most reproducible human evidence.

How is mitochondrial function measured in people?+

Muscle biopsy respirometry, phosphorus magnetic resonance spectroscopy for phosphocreatine recovery, and blood-based markers with more limited reliability.

What is mitohormesis?+

The concept that mild mitochondrial stress triggers adaptive responses that improve resilience — the reason blanket antioxidant dosing can blunt exercise adaptation.

What is cardiolipin?+

A phospholipid found only in the inner mitochondrial membrane that organises respiratory complexes; its composition changes with age and in mitochondrial disease.

Continue your research

SS-31 research

MOTS-c research

Oxidative stress